YANTAI DONGCHENG BIOCHEMICALS CO., LTD
Stock Code:002675
Company News
YOUR LOCATION:HOME >> NEWS
Bailushu- Nadroparin calcium for injection is awarded as "Yantai City Key Pharmaceutical Innovative Product" and "2018 Excellent Brand of Biochemical
Date【2019-01-07 07:59】 All:【】次

    On November 29, 2018, Yantai FDA successfully organized and held the conference of "Municipal Drug Safety Task and Year 2018 Pharmaceutical and Health Industry Innovation and Development Award ". Officials from government attended the conference. In order to motivate pharmaceutical enterprises’ enthusiasm and initiative of R&D as well as innovation, a total fund of 17,875,700 yuan is rewarded to the municipal pharmaceutical and health enterprises. In which, the reward for drug and medical equipment innovation is 7,375,700 yuan and our company’s Nadroparin calcium products are listed as Yantai city’s key pharmaceutical innovative product, acquiring a total reward of 3,107,000 yuan (in which, Bailishu’s reward is 2,910,000 yuan, Nadroparin calcium API’s reward is 197,000 yuan), ranked No.1 among the awarded 11 innovative products from 8 enterprises. Meanwhile, during the conference, officials from government highly affirm and praise our development and achievements in pharmaceutical innovation field.

    On December 9, 2018, China biochemical pharmaceutical industry association successfully held the annual meeting of year 2018 in Beijing. Our product Bailishu won honorary title of "2018 Excellent Brand Award of Biochemical and Biological drugs". It is the second time our company’s product obtains this title since last time in 2017 when our product chondroitin sulfate sodium acquired this prize. 

Previous:
Next:
CONTACT US
0535-6391521
Switchboard:86-535-6391521/6391522
Mailbox:zxu@dcb-group.com
Address:No.7 ChangBaiShan Road, Yantai Development Zone, ShanDong, China
COPYRIGHT 2014 YANTAI DONGCHENG BIOCHEMICALS CO., LTD